BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiely F, Foley J, Stone A, Cobbe E, Browne S, Murphy E, Kelsey M, Walsh-Crowley J, Eustace JA. Managing clinical trials during COVID-19: experience from a clinical research facility. Trials 2021;22:62. [PMID: 33461595 DOI: 10.1186/s13063-020-05004-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Rankin A, Gorman A, Cole J, Cadogan CA, Barry HE, Agus A, Logan D, Mcdowell C, Molloy GJ, Ryan C, Leathem C, Maxwell M, Brennan C, Gormley GJ, Ferrett A, Mccarthy P, Fahey T, Hughes CM, Murphy L, Kennedy G, Adams C, Martin L, Thompson J, Toase S, Boyd C, Mcquillan R, O’dwyer M; on behalf of the PolyPrime team. An external pilot cluster randomised controlled trial of a theory-based intervention to improve appropriate polypharmacy in older people in primary care (PolyPrime). Pilot Feasibility Stud 2022;8. [DOI: 10.1186/s40814-022-01161-6] [Reference Citation Analysis]
2 Reid JC, Molloy A, Strong G, Kelly L, O'Grady H, Cook D, Archambault PM, Ball I, Berney S, Burns KEA, D'Aragon F, Duan E, English SW, Lamontagne F, Pastva AM, Rochwerg B, Seely AJE, Serri K, Tsang JLY, Verceles AC, Reeve B, Fox-Robichaud A, Muscedere J, Herridge M, Thabane L, Kho ME; CYCLE Investigators. Research interrupted: applying the CONSERVE 2021 Statement to a randomized trial of rehabilitation during critical illness affected by the COVID-19 pandemic. Trials 2022;23:735. [PMID: 36056378 DOI: 10.1186/s13063-022-06640-y] [Reference Citation Analysis]
3 Abdul Razack HI, Aranjani JM, Mathew ST. Clinical trial transparency regulations: Implications to various scholarly publishing stakeholders. Science and Public Policy 2022. [DOI: 10.1093/scipol/scac041] [Reference Citation Analysis]
4 Phiri P, Yardley L, Elliot K, Barnard-kelly K, Raymont V, Rathod S, Hu J, Cavalini H, Shi JQ, Delanerolle G. Impact of SARS-Cov-2 on Clinical Trial Unit Staff: The EPIC Observational Study.. [DOI: 10.1101/2022.07.18.22277769] [Reference Citation Analysis]
5 Rymer JA, Kirtane AJ, Farb A, Malone M, Jaff MR, Seward K, Stephens D, Barakat MR, Krucoff MW. One-year follow up of vascular intervention trials disrupted by the COVID-19 pandemic: A use-case landscape. Cardiovascular Revascularization Medicine 2022. [DOI: 10.1016/j.carrev.2022.07.018] [Reference Citation Analysis]
6 Sherratt FC, Fisher P, Mathieson A, Cherry MG, Pettitt AR, Young B. Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study. Trials 2022;23:509. [PMID: 35717403 DOI: 10.1186/s13063-022-06453-z] [Reference Citation Analysis]
7 Boniface D, Tapia-Rico G. Oncology During the COVID-19 Pandemic: a Lockdown Perspective. Curr Oncol Rep 2022. [PMID: 35622263 DOI: 10.1007/s11912-022-01301-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Chatters R, Cooper CL, O'Cathain A, Murphy C, Lane A, Sutherland K, Burton C, Cape A, Tunnicliffe L. Learning from COVID-19 related trial adaptations to inform efficient trial design-a sequential mixed methods study. BMC Med Res Methodol 2022;22:128. [PMID: 35488193 DOI: 10.1186/s12874-022-01609-6] [Reference Citation Analysis]
9 Wittmann J, Groß M, Catani C, Schmidt T, Neldner S, Wilker S, May T, Ertl V, Rosner R, Zindler A, Odenwald M, Neuner F. The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT. Trials 2022;23:360. [PMID: 35477413 DOI: 10.1186/s13063-022-06288-8] [Reference Citation Analysis]
10 Pembroke S, Rogerson S, Coyne I. Conducting a randomised controlled trial of a psychosocial intervention for adolescents with type 1 diabetes during COVID-19: recommendations to overcome the challenges complicated by inconsistent public health guidelines on research. Trials 2022;23:362. [PMID: 35477434 DOI: 10.1186/s13063-022-06314-9] [Reference Citation Analysis]
11 Gray A. Mitigating the effects of COVID-19 on the work of a children's clinical research facility. Nurs Child Young People 2022. [PMID: 35128879 DOI: 10.7748/ncyp.2022.e1404] [Reference Citation Analysis]
12 Klatte K, Pauli-Magnus C, Love SB, Sydes MR, Benkert P, Bruni N, Ewald H, Arnaiz Jimenez P, Bonde MM, Briel M. Monitoring strategies for clinical intervention studies. Cochrane Database Syst Rev 2021;12:MR000051. [PMID: 34878168 DOI: 10.1002/14651858.MR000051.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ali JK, Riches JC. The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials. Cancers (Basel) 2021;13:5924. [PMID: 34885038 DOI: 10.3390/cancers13235924] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Tom M, Cohen EJ, LopezJimenez C, Hochman JS, Troxel AB, Jeng BH. Meeting the challenges of retention and enrollment of study participants in clinical trials during the COVID-19 pandemic from the study leadership perspective: Experience from the Zoster Eye Disease Study (ZEDS). Contemp Clin Trials Commun 2021;24:100875. [PMID: 34805615 DOI: 10.1016/j.conctc.2021.100875] [Reference Citation Analysis]
15 Anderson M. How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis. Bioanalysis 2021. [PMID: 34275327 DOI: 10.4155/bio-2021-0107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Myers B, van der Westhuizen C, Pool M, Hornsby N, Sorsdahl KR. Responding to COVID-19 threats to trial conduct: lessons learned from a feasibility trial of a psychological intervention for South African adolescents. Trials 2021;22:440. [PMID: 34243806 DOI: 10.1186/s13063-021-05400-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Solís-cordero K, Lerner R, Marinho P, Camargo P, Takey S, Fujimori E. Overcoming methodological challenges due to COVID-19 pandemic in a non-pharmacological caregiver-child randomly controlled trial. International Journal of Social Research Methodology. [DOI: 10.1080/13645579.2021.1933067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]